Immune Axonal Neuropathies Associated With Systemic Autoimmune Rheumatic Diseases

被引:15
|
作者
Tulba, Delia [1 ,2 ,3 ]
Popescu, Bogdan Ovidiu [1 ,3 ,4 ]
Manole, Emilia [4 ]
Baicus, Cristian [2 ,3 ,5 ]
机构
[1] Colentina Clin Hosp, Dept Neurol, Bucharest, Romania
[2] Colentina Clin Hosp, Colentina Res & Dev Ctr, Bucharest, Romania
[3] Carol Davila Univ Med & Pharm, Bucharest, Romania
[4] Victor Babes Natl Inst Pathol, Lab Cell Biol Neurosci & Expt Myol, Bucharest, Romania
[5] Colentina Clin Hosp, Dept Internal Med, Bucharest, Romania
关键词
immune axonal neuropathy; vasculitic neuropathy; sensorimotor polyneuropathy; mononeuritis multiplex; connective tissue disease; systemic vasculitis; systemic autoimmune rheumatic disease; small fiber neuropathy; HIGH-RESOLUTION SONOGRAPHY; ANCA-ASSOCIATED VASCULITIS; PERIPHERAL NEUROPATHY; LUPUS-ERYTHEMATOSUS; INTRAVENOUS CYCLOPHOSPHAMIDE; CLINICOPATHOLOGICAL FEATURES; NEUROLOGICAL MANIFESTATIONS; NERVOUS-SYSTEM; 1990; CRITERIA; CLASSIFICATION;
D O I
10.3389/fphar.2021.610585
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Immune axonal neuropathies are a particular group of immune-mediated neuropathies that occasionally accompany systemic autoimmune rheumatic diseases such as connective tissue dissorders and primary systemic vasculitides. Apart from vasculitis of vasa nervorum, various other mechanisms are involved in their pathogenesis, with possible therapeutic implications. Immune axonal neuropathies have highly heterogeneous clinical presentation and course, ranging from mild chronic distal sensorimotor polyneuropathy to severe subacute mononeuritis multiplex with rapid progression and constitutional symptoms such as fever, malaise, weight loss and night sweats, underpinning a vasculitic process. Sensory neuronopathy (ganglionopathy), small fiber neuropathy (sensory and/or autonomic), axonal variants of Guillain-Barre syndrome and cranial neuropathies have also been reported. In contrast to demyelinating neuropathies, immune axonal neuropathies show absent or reduced nerve amplitudes with normal latencies and conduction velocities on nerve conduction studies. Diagnosis and initiation of treatment are often delayed, leading to accumulating disability. Considering the lack of validated diagnostic criteria and evidence-based treatment protocols for immune axonal neuropathies, this review offers a comprehensive perspective on etiopathogenesis, clinical and paraclinical findings as well as therapy guidance for assisting the clinician in approaching these patients. High quality clinical research is required in order to provide indications and follow up rules for treatment in immune axonal neuropathies related to systemic autoimmune rheumatic diseases.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Neurological involvement in patients with systemic autoimmune rheumatic diseases: a descriptive study in an Egyptian cohort
    Attia, Doaa Hassan Sayed
    Fotouh, Alshaimaa Aboul
    Mohammed, Reem Hamdy Abdellatif
    EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2024, 60 (01):
  • [42] Could Lymphocyte Profiling be Useful to Diagnose Systemic Autoimmune Diseases?
    Alegria, Guillermo Carvajal
    Gazeau, Pierre
    Hillion, Sophie
    Daien, Claire I.
    Cornec, Divi Y. K.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2017, 53 (02) : 219 - 236
  • [43] A molecular taxonomy for systemic autoimmune rheumatic diseases (SARDs): learning lessons from oncology?
    Reynolds, John A.
    Bruce, Ian N.
    RHEUMATOLOGY, 2020, 59 (09) : 2193 - 2194
  • [44] Vitamin D and autoimmune rheumatic diseases
    Paola Caramaschi
    Alessandra Dalla Gassa
    Orazio Ruzzenente
    Alessandro Volpe
    Viviana Ravagnani
    Ilaria Tinazzi
    Giovanni Barausse
    Lisa M. Bambara
    Domenico Biasi
    Clinical Rheumatology, 2011, 30 : 443 - 444
  • [45] Investigation of anti-DFS70 antibody in patients with systemic autoimmune rheumatic diseases
    Bilal Olcay Peker
    Aslı Gamze Şener
    Emine Figen Tarhan
    Selçuk Kaya
    Clinical Rheumatology, 2019, 38 : 3627 - 3633
  • [46] Investigation of anti-DFS70 antibody in patients with systemic autoimmune rheumatic diseases
    Peker, Bilal Olcay
    Sener, Asli Gamze
    Tarhan, Emine Figen
    Kaya, Selcuk
    CLINICAL RHEUMATOLOGY, 2019, 38 (12) : 3627 - 3633
  • [47] The prevalence of systemic autoimmune rheumatic diseases in Canadian pediatric populations: administrative database estimates
    Shiff, Natalie Jane
    Lix, Lisa M.
    Joseph, Lawrence
    Duffy, Ciaran
    Tucker, Lori B.
    Svenson, Lawrence W.
    Belisle, Patrick
    Bernatsky, Sasha
    RHEUMATOLOGY INTERNATIONAL, 2015, 35 (03) : 569 - 573
  • [48] Innate immune response in systemic autoimmune diseases: a potential target of therapy
    Hejrati, Alireza
    Rafiei, Alireza
    Soltanshahi, Mohsen
    Hosseinzadeh, Shahnaz
    Dabiri, Mina
    Taghadosi, Mahdi
    Taghiloo, Saeid
    Bashash, Davood
    Khorshidi, Fatemeh
    Zafari, Parisa
    INFLAMMOPHARMACOLOGY, 2020, 28 (06) : 1421 - 1438
  • [49] Hepatic manifestations of autoimmune rheumatic diseases
    Soultati, Aspasia
    Dourakis, S.
    ANNALS OF GASTROENTEROLOGY, 2005, 18 (03): : 309 - 324
  • [50] The telomere/telomerase system in autoimmune and systemic immune-mediated diseases
    Georgin-Lavialle, Sophie
    Aouba, Achille
    Mouthon, Luc
    Londono-Vallejo, J. Arturo
    Lepelletier, Yves
    Gabet, Anne-Sophie
    Hermine, Olivier
    AUTOIMMUNITY REVIEWS, 2010, 9 (10) : 646 - 651